» Articles » PMID: 14983003

From Conversion to Aggregation: Protofibril Formation of the Prion Protein

Overview
Specialty Science
Date 2004 Feb 26
PMID 14983003
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

The ability to diagnose and treat prion diseases is limited by our current understanding of the conversion process of the protein from healthy to harmful isoform. Whereas the monomeric, benign species is well characterized, the misfolded conformations responsible for infectivity and neurodegeneration remain elusive. There is mounting evidence that fibrillization intermediates, or protofibrils, but not mature fibrils or plaques, are the pathogenic species in amyloid diseases. Here, we use molecular dynamics to simulate the conversion of the prion protein. Molecular dynamics simulation produces a scrapie prion protein-like conformation enriched in beta-structure that is in good agreement with available experimental data. The converted conformation was then used to model a protofibril by means of the docking of hydrophobic patches of the template structure to form hydrogen-bonded sheets spanning adjacent subunits. The resulting protofibril model provides a non-branching aggregate with a 3(1) axis of symmetry that is in good agreement with a wide variety of experimental data; importantly, it was derived from realistic simulation of the conversion process.

Citing Articles

Intrinsic determinants of prion protein neurotoxicity in : from sequence to (dys)function.

Cembran A, Fernandez-Funez P Front Mol Neurosci. 2023; 16:1231079.

PMID: 37645703 PMC: 10461008. DOI: 10.3389/fnmol.2023.1231079.


Conversion of Helix 1 into a Loop in Prion Protein Misfolding.

Tavsanli A, Balta B ACS Omega. 2023; 8(7):7191-7200.

PMID: 36844589 PMC: 9948551. DOI: 10.1021/acsomega.3c00212.


Vaccines for prion diseases: a realistic goal?.

Napper S, Schatzl H Cell Tissue Res. 2023; 392(1):367-392.

PMID: 36764940 PMC: 9918406. DOI: 10.1007/s00441-023-03749-7.


The role of α-sheet structure in amyloidogenesis: characterization and implications.

Prosswimmer T, Daggett V Open Biol. 2022; 12(11):220261.

PMID: 36416010 PMC: 9682440. DOI: 10.1098/rsob.220261.


Location of the cross-β structure in prion fibrils: A search by seeding and electron spin resonance spectroscopy.

Chu B, Tsai R, Hung C, Kuo Y, Chen E, Chiang Y Protein Sci. 2022; 31(6):e4326.

PMID: 35634767 PMC: 9112485. DOI: 10.1002/pro.4326.


References
1.
Heller J, Kolbert A, Larsen R, Ernst M, Bekker T, Baldwin M . Solid-state NMR studies of the prion protein H1 fragment. Protein Sci. 1996; 5(8):1655-61. PMC: 2143492. DOI: 10.1002/pro.5560050819. View

2.
Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

3.
Inouye H, Kirschner D . Polypeptide chain folding in the hydrophobic core of hamster scrapie prion: analysis by X-ray diffraction. J Struct Biol. 1998; 122(1-2):247-55. DOI: 10.1006/jsbi.1998.3998. View

4.
Wetzel R . Ideas of order for amyloid fibril structure. Structure. 2002; 10(8):1031-6. DOI: 10.1016/s0969-2126(02)00809-2. View

5.
Schwarz A, Kratke O, Burwinkel M, Riemer C, Schultz J, Henklein P . Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci Lett. 2003; 350(3):187-9. DOI: 10.1016/s0304-3940(03)00907-8. View